US 7,001,602 B2Granted

Use of botulinum toxin therapy for urinary incontinence and related disorders

AssigneeThe Regents of the University of Colorado

InventorRichard A. Schmidt

Life of this patent

Estimating the term…

Abstract

The present invention relates to methods for treating neurological-urological conditions. This is accomplished by administration of at least one neurotoxin.

Claims13

Dependent claims

A method for treating urinary incontinence in a patient, the method comprising the step of administering to a patient with urinary incontinence a botulinum toxin, thereby treating the urinary incontinence.

Dependencies are inferred from the claim text.

Facts

Application: 10/685,995Filed 14 Oct 2003 · continuation
Priority: 15 Jul 1997
Published: US 2004/0126380 A11 Jul 2004
Granted: 21 Feb 2006
Term ends: Not estimatedThe source records don’t support an estimate.

Classification24 codes

A61K 38/4893
Metalloendopeptidases , e.g. collagenase: botulinum neurotoxin
A61K 31/165
Amides, e.g. hydroxamic acids: having aromatic rings, e.g. colchicine, atenolol, progabide
A61K 31/529
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim: forming part of bridged ring systems
A61K 38/1703
From animals; from humans: from vertebrates

Family

Application60/052,580Us provisional application · filed 15 Jul 1997
Application09/463,040Parent of this continuation · filed 17 Jan 2000
Application09/978,982Parent of this continuation · filed 15 Oct 2001
US 2004/0126380 A1Pre-grant publication · published 1 Jul 2004
US 6,667,041 B2Parent of this continuation
US 6,365,164 B1Parent of this continuation
US 2002/0025327 A1Published application
US 7,001,602 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results